# A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis

> **NCT03139981** · PHASE1 · COMPLETED · sponsor: **Asana BioSciences** · enrollment: 36 (actual)

## Conditions studied

- Dermatitis, Atopic
- Dermatitis Eczema
- Dermatitis, Eczematous

## Interventions

- **DRUG:** ASN002
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03139981
- **Lead sponsor:** Asana BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2017-11-05
- **Final completion:** 2017-12-05
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03139981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03139981, "A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03139981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*